The first online platform (CoVex) for SARS-CoV-2 and SARS-CoV-1 host interactome exploration and drug identification has been set up by Prof. Jan Baumbach, core member of Open Multiscale Systems Medicine (OpenMultiMed) Action, and his team at the Technical University of Munich, with the help of Prof. Harald Schmidt, Chair of the Action, and of two other researchers in the network.

CoVex is a user-friendly tool which shows how human and viral proteins interact and implements systems medicine algorithms for network-based prediction of drugs against SARS-CoV-2 and similar viruses. It provides the science community with direct access to basic network medicine algorithms integrating drug-protein-virus interactions.

CoVex is now available in open source and the development process and functionalities can be found here.

To know more about this useful tool, please visit the news page on the COST website: https://www.cost.eu/news/cost-action-contribute-online-tool-drug-repurposing-against-sars-cov-2/#